Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Inhibition of mTOR by rapamycin does not improve hypoxic pulmonary hypertension-induced right heart failure in old mice

Experimental Gerontology(2021)10.1016/j.exger.2021.111395Source: DataRank Database

Inhibition of mTOR by rapamycin does not improve hypoxic pulmonary hypertension-induced right heart failure in old mice is a research paper published in Experimental Gerontology (2021). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.05)OA: greenTopics (33)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Jacob A. Schlatter,Ross Cook,Musharraf Yusifova,Danielle R. Bruns ORCID,Benjamin D. McNair

Live enrichment

PubMed:33971279 PMC:PMC8248895 OpenAlex:https://openalex.org/W3160056530

National Institute on Aging

Grant: K01 AG058810

National Institute on Aging

Grant: 2P20GM103432

NIGMS NIH HHS

Grant: P20 GM103432

National Institutes of Health

FWCI

1.05

Citation Percentile

0.8%

Citation Trend

2021

2024

2025

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8248895

BRONZEhttps://www.sciencedirect.com/science/article/am/pii/S0531556521001777

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8248895

publisherhttps://api.elsevier.com/content/article/PII:S0531556521001777?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0531556521001777?httpAccept=text/plain

Fields of Study

Pulmonary Hypertension Research and TreatmentsHigh Altitude and HypoxiaChronic Obstructive Pulmonary Disease (COPD) ResearchMedicine

MeSH Terms

AnimalsHypoxiaHeart FailureHypertension, PulmonaryMaleVentricular Dysfunction, RightSirolimusMiceTOR Serine-Threonine Kinases

Keywords

Hypoxia (environmental)PI3K/AKT/mTOR pathwayPulmonary hypertensionHeart failureMechanistic target of rapamycinInternal medicineMedicineSirolimusVentricular remodelingCardiologyPulmonary arteryBiologyChemistrySignal transductionOxygenCell biologyAgingHypoxiaRapamycinRight Ventricle

Sustainable Development Goals

SDG 0: Good health and well-being